These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2238296)

  • 1. Management of superficial G2 (pTa and pT1) bladder cancer.
    Thorpe AC; Jenkins BJ; Martin JE
    Urology; 1990 Nov; 36(5):395-7. PubMed ID: 2238296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical evaluation of grade 3 superficial bladder cancer].
    Shinohara M; Inoue Y; Itakura H; Munakata A; Kinoshita K
    Nihon Hinyokika Gakkai Zasshi; 1996 Jun; 87(6):892-9. PubMed ID: 8753007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
    Witjes WP; Witjes JA; Oosterhof GO; Debruyne MJ
    Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy for carcinoma in situ of the bladder.
    Jenkins BJ; England HR; Fowler CG; Tiptaft RC; Badenoch DF; Paris AM; Oliver RT; Blandy JP
    Br J Urol; 1988 Apr; 61(4):326-9. PubMed ID: 3133011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of adjuvant intravesical Bacillus Calmette-Guérin therapy for grade 3 superficial bladder cancer].
    Yumura Y; Oogo Y; Takase K; Hamano A; Yamashita Y; Noguchi S; Satomi Y
    Hinyokika Kiyo; 2004 Nov; 50(11):767-71. PubMed ID: 15628536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
    Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
    J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological stage review is indicated in primary pT1 bladder cancer.
    van Rhijn BW; van der Kwast TH; Kakiashvili DM; Fleshner NE; van der Aa MN; Alkhateeb S; Bangma CH; Jewett MA; Zlotta AR
    BJU Int; 2010 Jul; 106(2):206-11. PubMed ID: 20002439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of superficial recurrences in an irradiated bladder after combined-modality organ-preserving therapy.
    Weiss C; Wittlinger M; Engehausen DG; Krause FS; Ott OJ; Dunst J; Sauer R; Rödel C
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1502-6. PubMed ID: 17935905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
    Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R
    Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes of second transurethral resection in non-muscle invasive high-grade bladder cancer: a retrospective, multi-institutional, collaborative study.
    Kamiya N; Suzuki H; Suyama T; Kobayashi M; Fukasawa S; Sekita N; Mikami K; Nihei N; Naya Y; Ichikawa T
    Int J Clin Oncol; 2017 Apr; 22(2):353-358. PubMed ID: 27744487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: is immediate cystectomy always necessary?
    Wo JY; Shipley WU; Dahl DM; Coen JJ; Heney NM; Kaufman DS; Zietman AL
    BJU Int; 2009 Jul; 104(2):179-83. PubMed ID: 19154448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
    Solsona E; Iborra I; Ricos JV; Monros JL; Rubio J; Almenar S
    J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802.
    Tester W; Caplan R; Heaney J; Venner P; Whittington R; Byhardt R; True L; Shipley W
    J Clin Oncol; 1996 Jan; 14(1):119-26. PubMed ID: 8558186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Squamous differentiation in patients with superficial bladder urothelial carcinoma is associated with high risk of recurrence and poor survival.
    Li G; Yu J; Song H; Zhu S; Sun L; Shang Z; Niu Y
    BMC Cancer; 2017 Aug; 17(1):530. PubMed ID: 28789622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis by step sectioning of early invasive bladder cancer with special reference to G3.pT1 disease.
    Kakizoe T; Tobisu K; Mizutani T; Tsutsumi M; Tanaka Y; Sakamoto M
    Jpn J Cancer Res; 1992 Dec; 83(12):1354-8. PubMed ID: 1483949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphovascular invasion and the presence of more than three tumors are associated with poor outcomes of muscle-invasive bladder cancer after bladder-conserving therapies.
    Zhang M; Tao R; Zhang C; Shen Z
    Urology; 2010 Oct; 76(4):902-7. PubMed ID: 20709377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy and follow-up of bladder cancer].
    Meyer D; Schmid HP; Engeler DS
    Wien Med Wochenschr; 2007; 157(7-8):162-9. PubMed ID: 17492413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bladder cancer in nonagenarians: a multicentre study of 123 patients.
    Eredics K; Bretterbauer KM; Comploj E; Friedl A; Gschliesser T; Lenart S; Seklehner S; Wimpissinger F; Madersbacher S
    BJU Int; 2018 Dec; 122(6):1010-1015. PubMed ID: 29804311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence and treatment of urinary bladder cancer after failure in radiotherapy.
    Salminen E
    Cancer; 1990 Dec; 66(11):2341-5. PubMed ID: 1700928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical study of G3 superficial bladder cancer without concomitant CIS treated with conservative therapy.
    Saika T; Tsushima T; Nasu Y; Arata R; Kaku H; Kusaka N; Kumon H
    Jpn J Clin Oncol; 2002 Nov; 32(11):461-5. PubMed ID: 12499418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.